SAR 29.0
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 155.88 Million SAR | 30.98% |
2022 | 119.01 Million SAR | 4.66% |
2021 | 113.72 Million SAR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 160.34 Million SAR | 2.86% |
2023 FY | 155.88 Million SAR | 30.98% |
2023 Q4 | 155.88 Million SAR | 8.94% |
2023 Q2 | 143.09 Million SAR | 20.23% |
2022 Q4 | 119.01 Million SAR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 44.67 Million SAR | -248.953% |
Al-Dawaa Medical Services Company | 2.23 Billion SAR | 93.041% |
Nahdi Medical Company | 265.09 Million SAR | 41.196% |
Al-Razi Medical Co. | 11.02 Million SAR | -1314.307% |